Clinical Trial Update: Microbiological Effect of 0.12% Chlorhexidine Digluconate and 0.05% Cetylpyridinium Chloride vs Probiotics (Lactobacillus Reuteri Prodentis) on Porphyromonas Gingivalis. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the microbiological effects of 0.12% chlorhexidine digluconate and 0.05% cetylpyridinium chloride mouthwash compared with Lact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Diseases
• Type 2 Diabetes Mellitus

Drugs mentioned

• Cetylpyridinium chloride 0.05% mouthwash (Cetylpyridinium chloride)
• Chlorhexidine digluconate 0.12% mouthwash (Chlorhexidine digluconate)
• Lactobacillus reuteri Prodentis (Lactobacillus reuteri)

Snippet

Sponsor: Universidad de Colima | Conditions: Periodontal Diseases, Diabetes Mellitus Type 2 | Phase 4 | Status: ACTIVE_NOT_RECRUITING